Regenerative Medicine for Arthritis: 4 Treatments That Address the Biological Source

What Regenerative Medicine for Arthritis Is

Regenerative medicine for arthritis is the application of biological and physical therapies designed to address the underlying tissue degeneration, inflammation, and cartilage loss that drive arthritis symptoms, rather than simply suppressing pain perception. Osteoarthritis, the most common form, is characterized by progressive cartilage breakdown, synovial inflammation, subchondral bone changes, and reduced joint space. Standard management with NSAIDs and cortisone injections addresses pain and inflammation on a temporary basis without altering the degenerative trajectory. Regenerative medicine introduces biologically active agents and physical stimuli that modulate the joint environment toward repair and reduced inflammatory activity.

At Rebuild Regen Medical Clinic, arthritis is approached as a condition with a biological root that is addressable, not simply a structural inevitability.

Treatment 1: DayZero™ Stem Cell Therapy

DayZero™ umbilical cord stem cells introduced intra-articularly deliver mesenchymal stem cells that migrate to the site of inflammation, release anti-inflammatory cytokines (including IL-10 and TGF-beta), and provide paracrine signals that reduce synoviocyte activation. In early-to-moderate osteoarthritis, MSC injection has been documented to reduce pain scores and improve function. The procedure is performed under physician supervision by [MD_PLACEHOLDER], Medical Director, in compliance with Florida SB 1768. See Florida Stem Cell Law SB 1768 for regulatory context.

Treatment 2: Platelet-Rich Plasma

PRP therapy delivers a concentrated dose of the patient's own growth factors directly into the arthritic joint space. The growth factors present in platelet-rich plasma, including IGF-1, PDGF, and FGF, stimulate chondrocyte activity and reduce metalloproteinase enzymes that degrade cartilage matrix. Multiple randomized studies show PRP outperforms hyaluronic acid injections for knee osteoarthritis in medium and long-term outcomes. PRP is often the appropriate starting point for patients with early-to-moderate arthritis who are not yet ready for stem cell therapy.

Treatment 3: Exosome Therapy

DayZero™ exosomes carry micro-RNA and protein signals that reduce the pro-inflammatory synovial environment without introducing live cells. For patients who prefer a non-cellular biologic or who are combining arthritis treatment with systemic anti-aging goals, exosome therapy addresses the joint's inflammatory microenvironment. The 150B and 250B particle concentrations are the most commonly used for joint applications.

Treatment 4: Knee Decompression With the Knee on Trac

For knee arthritis specifically, the Knee on Trac mechanical decompression device creates negative intrajoint pressure that reduces bone-on-bone contact forces, improves synovial fluid distribution, and supports cartilage nutrition. This physical intervention complements biologic therapies and is particularly effective for patients whose pain is substantially position-dependent and load-driven. A combined protocol of biologic injection plus decompression sessions addresses both the biological and mechanical drivers of knee arthritis simultaneously.

For the full clinical picture on knee arthritis treatment, see the stem cell therapy service page and the knee decompression article.

Is Regenerative Medicine the Right Approach for Your Arthritis?

The four treatments above are most effective in grades 1 through 3 osteoarthritis, where cartilage is present but degenerating. Grade 4 arthritis with complete cartilage loss and bone-on-bone contact across the entire joint surface presents a different clinical situation. Biologics in that context can still reduce pain and inflammation, but cannot restore cartilage that is absent. The right intervention depends on imaging findings and functional goals reviewed at consultation. Read the complete guide to stem cell therapy for the full candidacy framework.

Does Regenerative Medicine Stop Arthritis Progression?

No treatment currently reverses advanced osteoarthritis or halts progression in every patient. Regenerative treatments reduce the inflammatory load on the joint and support the body's repair environment, which in well-selected patients slows the rate of deterioration and reduces symptoms significantly.

How Many Injections Are Needed?

Most patients with knee or hip osteoarthritis receive one to three biologic injections over a course of 3 to 6 months, combined with decompression sessions. Response is evaluated at the 6 to 8 week mark after the first injection.

When Surgical Intervention Is Appropriate

End-stage joint destruction requiring total replacement, significant ligamentous instability requiring reconstruction, and symptomatic osteonecrosis requiring bone grafting are conditions where surgery is the appropriate primary intervention, not a regenerative alternative to avoid.